Prognostic impact of targetable driver alterations in resected early-stage lung cancer.

Saved in:
Bibliographic Details
Title: Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Authors: Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Konjic S; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Schlintl V; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Absenger G; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Medical Department III for Haematology and Oncology, School of Medicine, Technical University of Munich, Munich, Germany.; BioTechMed-Graz, Graz, Austria., Lindenmann J; Division of Thoracic Surgery, Department of Surgery, Medical University of Graz, Graz, Austria., Swatek P; Division of Thoracic Surgery, Department of Surgery, Medical University of Graz, Graz, Austria., John N; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., John T; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Wurm R; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Zacharias M; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Posch F; Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Hochmair MJ; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna, Austria., Fabikan H; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna, Austria., Weinlinger C; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna, Austria., Illini O; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna, Austria., Horvath L; Division of Hematology and Oncology, Department of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria., Gamerith G; Division of Hematology and Oncology, Department of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Division of Hematology and Oncology, Department of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria., Augustin F; Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Source: Translational lung cancer research [Transl Lung Cancer Res] 2024 Nov 30; Vol. 13 (11), pp. 3096-3105. Date of Electronic Publication: 2024 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2218-6751
DOI:10.21037/tlcr-24-433